Description

Premium TB500 – UK Research Grade Peptide

Product Overview

If you are looking for TB500 for laboratory research, Cocer Peptides supplies a high-purity, research-grade version of this synthetic peptide fragment. TB500 is a synthetic version of the active region of thymosin beta-4 (Tβ4), an endogenous protein upregulated in response to tissue injury. Its sequence is N-Acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ), corresponding to the actin-binding active site within the full thymosin beta-4 protein.

Researchers studying this compound are typically investigating tissue repair mechanisms, cell migration, and angiogenesis pathways. According to a therapeutic peptide review published in NIH PMC, the active segment within TB500 promotes actin polymerization, progenitor cell recruitment, and enhanced cellular migration—processes integral to wound healing. Preclinical studies have suggested benefit in tendon and muscle repair, with observed anti-inflammatory effects and proangiogenic activity.

Important Notice: This product is supplied strictly for laboratory research use only and is not intended for human or veterinary use. TB500 is not approved by the MHRA or FDA for any medical use. The British College of Aesthetic Medicine (BCAM) has warned that internet-sourced “research peptides” are frequently sold under the guise of being “not for human consumption,” and their promotion as actual treatments breaches UK safety and regulatory boundaries.

Product Specifications

The structural identity of this peptide was first characterised in a 2012 study published in Drug Testing and Analysis, which identified the N-terminal acetylated 17-23 fragment of thymosin beta-4 in TB500 formulations.

Mechanism of Action

Actin Polymerization and Cell Migration

The primary mechanism studied in TB500 peptide research involves actin regulation. According to a 2012 doping control analysis published in the Journal of Chromatography A, the peptide segment LKKTETQ is the active site within thymosin beta-4 responsible for actin binding, cell migration, and wound healing. By modulating actin dynamics, it facilitates the migration of reparative cells to injury sites.

Angiogenesis and Tissue Repair

Research has examined its proangiogenic properties. Studies have shown that TB500 promotes endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, and collagen deposition, while decreasing inflammation. These mechanisms are consistent with the broader thymosin beta-4 literature, which documents its role in tissue regeneration and repair.

Molecular Pathways

Emerging research has identified additional pathways influenced by this compound. According to documentation from BenchChem, thymosin beta-4 has been shown to activate the Wnt/β-catenin pathway, which plays a crucial role in cell fate determination, proliferation, and stem cell maturation during regeneration. The peptide also upregulates matrix metalloproteinases (MMPs) such as MMP-2 and MMP-9, which remodel the extracellular matrix to facilitate cell migration.

Research Applications

Musculoskeletal Tissue Research

A 2026 study published in Joint Diseases and Related Surgery evaluated this compound in a rat Achilles tendon healing model. The study found that TB500 peptide was associated with improved histopathological parameters and extracellular matrix organisation, demonstrating a significant biomechanical advantage at four weeks with higher maximum load to failure values compared to controls.

Cardiovascular Research Signals

Preclinical research has explored TB500 in cardiovascular contexts. According to a review published on GlobalRPH, thymosin beta-4 has demonstrated potential cardiovascular benefits, with studies showing reduced infarct size and increased epicardial progenitor cell migration in animal models. These findings have contributed to interest in the compound as a research tool for cardiac repair mechanisms.

Wound Healing Research

The peptide has been studied extensively in wound healing models. A 2024 study published in the Journal of Chromatography B investigated the metabolism and biological activity of TB500 and its metabolites, finding that the metabolite Ac-LKKTE showed significant wound healing activity in fibroblast experiments. This research suggests that the wound-healing effects reported for TB500 may be partly attributed to its metabolites.

Cellular Signalling Studies

Research on the TB500 peptide enables investigation of actin regulation and cytoskeletal dynamics in controlled experimental systems. The peptide’s interaction with the Wnt/β-catenin pathway and MMP expression provides multiple research targets for studying tissue regeneration mechanisms.

Quality and Purity

Every batch of Cocer Peptides TB500 undergoes rigorous quality control:

• ≥99% purity verified by HPLC

• Molecular weight confirmed by mass spectrometry

• Batch/lot number matching the vial label

• Certificate of Analysis (COA) available on request

Research-grade material requires batch-level analytical certification. The Medicines and Healthcare products Regulatory Agency (MHRA) has warned against purchasing unlicensed medicines and research peptides online, noting that such products may be contaminated, mislabelled, or of unknown potency. A 2026 advisory from Dana-Farber Cancer Institute noted that unapproved peptides are not guaranteed to be pure or to contain a specified dose, and that some peptides have mechanisms that could theoretically promote tumor growth.

Frequently Asked Questions

What is TB500?

TB500 peptide is a synthetic version of the active region of thymosin beta-4, with the sequence Ac-LKKTETQ. It is studied for its role in actin binding, cell migration, angiogenesis, and wound healing.

What is the TB500 sequence?

The sequence is N-Acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ), corresponding to the 17-23 fragment of thymosin beta-4.

Is TB500 legal in the UK?

TB500 is supplied strictly for in-vitro laboratory research use only. It is not a licensed medicine and is not authorised for human or veterinary use. The British College of Aesthetic Medicine (BCAM) has warned that UK regulations prohibit the advertising of unlicensed medicines to the public.

What purity level can I expect?

Our TB500 is provided at ≥99% purity, verified by HPLC with third-party testing.

How should it be stored?

Store lyophilized powder at -20°C, protected from light and moisture. Reconstituted material should follow standard laboratory protocols.

Is this product suitable for human use?

No. This product is supplied strictly for research purposes only and is not intended for human or veterinary use. The FDA has not approved TB500 for any medical use, and human clinical trial data remain absent.

Conclusion

TB500 peptide represents a research tool for investigating tissue repair mechanisms, actin regulation, and angiogenic signalling. With its high-purity formulation and comprehensive quality documentation, this product enables researchers to study thymosin beta-4 fragment pharmacology in controlled laboratory settings. For UK laboratories sourcing this peptide for research applications, Cocer Peptides offers documented composition, ≥99% purity, and batch-specific COA support. Researchers should note that TB500 is prohibited by WADA under section S2.3 and that no human clinical trials have established its safety or efficacy.

Ready to Advance Your Research?

Order premium TB500 for your laboratory today.

Buy TB500 Now | Contact Our Research Team